Atlas Trials

Immune Profile of Acute Myeloid Leukemia Patients Receiving Azacitidine Plus Venetoclax Induction Chemotherapy

Clinical trial NCT06279572 · RECRUITING

Trial details

NCT number
NCT06279572
Sponsor
Mayo Clinic
Status
RECRUITING
Study type
OBSERVATIONAL
Acute Myeloid Leukemia
Start date
2021-04-22
Primary completion
2027-12-31
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.